Christiane Blankenstein

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

Johannes Levin, Sylvia Maaß, Madeleine Schuberth et al. · The Lancet Neurology · 2019 · 126 citations · Full text

Life Sciences, Pharmacotherapy, Nutritional Epidemiology +3

Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial

Gerrit Burkhardt, Ulrike Kumpf, Alexander Crispin et al. · The Lancet · 2023 · 92 citations

Pharmacy, Pharmacotherapy, Psychiatry +15

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis

Paul Lingor, Markus Weber, William Camu et al. · Frontiers in Neurology · 2019 · 80 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial

Gabriele Multhoff, Sophie Seier, Stefan Stangl et al. · Clinical Cancer Research · 2020 · 65 citations · Full text

Medicine, Immunology, Oncology +16

Intraoperative Wound Irrigation for the Prevention of Surgical Site Infection After Laparotomy

Tara Mueller, Victoria Kehl, Rebekka Dimpel et al. · JAMA Surgery · 2024 · 21 citations · Full text

Medicine, Surgery, General Surgery +16